Pioglitazone
Product Images NDC 68151-3798

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 68151-3798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pioglitazone Hydrochloride Chemical Structure (3c52f60a 9068 4606 8056 02cebd614d74 01)

Chemical structure of Pioglitazone hydrochloride, showing its molecular arrangement including aromatic rings, heteroatoms, and functional groups, with the HCl salt form indicated.*

FDA Label Image

Figure1 (3c52f60a 9068 4606 8056 02cebd614d74 02)

A line graph depicting the mean values over 26 weeks comparing placebo and three dosage groups (15 mg, 30 mg, and 45 mg). The x-axis represents weeks, while the y-axis shows mean values. Different colored lines and markers distinguish the placebo from the dosage groups.*

FDA Label Image

Label Image (68151 3798)

Pioglitazone HCl 30 mg tablet label showing manufacturer Teva, lot number C19221, and expiration date 07/14. The label includes a barcode with the numbers 0000003798 and indicates the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.